Cumberland Pharmaceuticals (CPIX) shares surged 132% in recent Tuesday premarket activity, a day after it said the US Food and Drug Administration approved its supplemental new drug application for acetadote, simplifying the administration of the dosing regimen.
Cardiff Oncology (CRDF) stock soared 38% after it said that initial results from a phase 2 clinical trial of its cancer treatment candidate onvansertib demonstrated an overall 57% objective response rate in participants with a specific metastatic colorectal cancer.
Alaska Air Group (ALK) shares were up 11% after it launched new nonstop connections from Seattle to Tokyo and Seoul starting next year and issued better-than-expected 2025 earnings per share guidance.
American Airlines Group (AAL) stock was 3% higher after Bernstein upgraded it to outperform from market perform and raised its price target to $24 from $14.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。